Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.
CAT No: R1997
CAS No:19825-63-9
Chemical Name:(3,6,6,9-tetramethyl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) acetate
Pirnabine is a synthetic cannabinoid derivative characterized by its unique naphthoylindole structure, which imparts distinct pharmacological properties relevant to cannabinoid receptor research. As a non-classical cannabinoid, it serves as a valuable chemical tool for investigating the molecular interactions and signaling pathways associated with the endocannabinoid system. Its structural features and receptor affinity profile make it of particular interest for studies aiming to dissect the functional roles of cannabinoid receptors in various biochemical and physiological processes. The compound's availability as a research-use only reagent enables scientists to explore complex neurochemical networks and intracellular signaling mechanisms without the confounding variables associated with endogenous ligands.
Receptor Binding Studies: Pirnabine is widely utilized in receptor binding assays to elucidate the affinity and selectivity of cannabinoid ligands for CB1 and CB2 receptors. By serving as a reference compound or comparator, it allows researchers to quantify binding kinetics and to map ligand-receptor interactions at a molecular level. Such studies are foundational for advancing the understanding of cannabinoid receptor pharmacology, guiding the rational design of novel ligands, and identifying structural determinants that govern receptor specificity.
Signal Transduction Analysis: In cellular systems, pirnabine is instrumental for probing downstream signaling cascades initiated by cannabinoid receptor activation. Its application in G-protein coupled receptor (GPCR) models enables the assessment of second messenger responses, such as cyclic AMP modulation, calcium flux, and kinase pathway activation. These investigations contribute to the broader understanding of how synthetic cannabinoids modulate intracellular signaling and may reveal previously uncharacterized regulatory nodes within cannabinoid-mediated pathways.
Structure-Activity Relationship (SAR) Research: The distinct chemical scaffold of pirnabine makes it a valuable asset in structure-activity relationship studies. By comparing its biological activity with that of other cannabinoid analogs, researchers can delineate the impact of specific structural modifications on receptor binding and functional outcomes. Such SAR analyses are crucial for identifying key pharmacophores and for optimizing the design of next-generation cannabinoid research compounds with tailored properties.
Neurochemical Profiling: The compound is frequently employed in neurochemical assays to investigate its effects on neurotransmitter release, synaptic plasticity, and neuronal excitability. Through the use of in vitro and ex vivo models, scientists can evaluate how synthetic cannabinoids influence neurotransmission and neural circuit dynamics. These studies are essential for mapping the broader neuromodulatory roles of the endocannabinoid system and for identifying new experimental paradigms in neuropharmacology.
Analytical Reference Standard: Pirnabine serves as a reference standard in analytical chemistry applications, particularly in the development and validation of chromatographic methods for synthetic cannabinoid detection. Its well-characterized physicochemical properties and stability profile make it suitable for use in quality control, forensic analysis, and method development in research laboratories. Employing it as a standard enhances the accuracy and reliability of quantitative assays, supporting robust analytical workflows in cannabinoid research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.